Jeffrey L Anderson

Publication Activity (10 Years)

Years Active: 2015-2022
Publications (10 Years): 10

Top Topics

Angiotensin Converting Enzyme

Randomized Controlled Trial

Atrial Fibrillation

Top Venues

Journal of cardiovascular electrophysiology

Journal of cardiovascular pharmacology and therapeutics

Future cardiology

European heart journal open

This page only lists publications with an associated author ORCID identifier.

Publications

Bruce S Stambler, Francis Plat, Philip T Sager, Silvia Shardonofsky, Douglas Wight, Diane Potvin, Amritanshu Shekhar Pandey, James E Ip, Benoit Coutu, Blandine Mondésert, Laurence D Sterns, Matthew Bennett, Jeffrey L Anderson, Roger Damle, Ronald Haberman, Alan John Camm
First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301). Circulation. Arrhythmia and electrophysiology (2022)
Daniel L Varela, Tyson S Burnham, Heidi T May, Tami L Bair, Benjamin Adam Steinberg, Joseph B Muhlestein, Jeffrey L Anderson, Kirk U Knowlton, Thomas Jared Bunch
Economics and outcomes of sotalol in-patient dosing approaches in patients with atrial fibrillation. Journal of cardiovascular electrophysiology 33 (3) (2022)
Jeffrey L Anderson, Heidi T May, Stacey Knight, Tami L Bair, Benjamin D Horne, Kirk U Knowlton
Association of Rhesus factor blood type with risk of SARS-CoV-2 infection and COVID-19 severity. British journal of haematology 197 (5) (2022)
Jeffrey L Anderson, Stacey Knight, Raymond O McCubrey, Heidi T May, Steve Mason, Thomas J Bunch, David B Min, Michael J Cutler, Viet T Le, Joseph B Muhlestein, Kirk U Knowlton
Absent or Mild Coronary Calcium Predicts Low-Risk Stress Test Results and Outcomes in Patients Considered for Flecainide Therapy. Journal of cardiovascular pharmacology and therapeutics 26 (6) (2021)
Jeffrey L Anderson, Kirk U Knowlton, J Brent Muhlestein, Tami L Bair, Viet T Le, Benjamin D Horne
Evaluation of TReatment With Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer: ERACER-An Observational Cohort Study. Journal of cardiovascular pharmacology and therapeutics 26 (4) (2021)
Kevin S Shah, Mary Elizabeth Hale Hammond, Stavros G Drakos, Jeffrey L Anderson, James C Fang, Kirk U Knowlton, Robin M Shaw
SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges. Future cardiology 17 (7) (2021)
Ciera L Bartholomew, Joseph B Muhlestein, Heidi T May, Viet T Le, Oxana Galenko, Kelly Davis Garrett, Cherie Brunker, Ramona O Hopkins, John F Carlquist, Kirk U Knowlton, Jeffrey L Anderson, Bruce W Bailey, Benjamin D Horne
Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial. European heart journal open 1 (2) (2021)
Jeffrey L Anderson, Victoria Jacobs, Heidi T May, Tami L Bair, Barry A Benowitz, Donald L Lappe, Joseph B Muhlestein, Kirk U Knowlton, T Jared Bunch
Free thyroxine within the normal reference range predicts risk of atrial fibrillation. Journal of cardiovascular electrophysiology 31 (1) (2019)
Steve Mason, Jeffrey S Osborn, Ritesh Dhar, Allison Tonkin, Jon-David Ethington, Viet Le, Jose Benuzillo, Donald L Lappe, Kirk U Knowlton, T Jared Bunch, Jeffrey L Anderson
Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe. Journal of cardiovascular electrophysiology 28 (12) (2017)
Benjamin D Horne, Joseph B Muhlestein, Jeffrey L Anderson
Health effects of intermittent fasting: hormesis or harm? A systematic review. The American journal of clinical nutrition 102 (2) (2015)